{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:06:15Z","timestamp":1790831175899,"version":"4.1.0"},"reference-count":39,"publisher":"Rockefeller University Press","issue":"9","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1997,11,3]]},"abstract":"<jats:p>The antiviral nature of tumor necrosis factor (TNF) is generally well accepted. TNF appears to induce multiple antiviral mechanisms, and to synergize with interferon (IFN)-\u03b3 in promoting antiviral activities. We infected TNF receptor (TNFR)-deficient mice with the virulent murine pathogen, ectromelia virus (EV), and observed that otherwise resistant mice were susceptible to lethal infection. To study the molecular basis of the antiviral action of TNF, mice were infected with a recombinant vaccinia virus encoding murine TNF (VV-HA-TNF). In normal mice, the replication of VV-HA-TNF was highly attenuated. In contrast, mice in which the TNFR type 1 (p55) or the TNFR type 2 (p75) were genetically disrupted showed a moderate defect in their capacity to clear the TNF-encoding virus. The contribution of both TNF receptors to the control of VV-HA-TNF was confirmed by the enhanced replication of VV-HA-TNF in mice deficient for both p55 and p75. These observations were corroborated by infecting TNFR-deficient mice with EV. For both infections, the p55 and p75 TNFRs were necessary to maintain normal levels of resistance. Thus, the antiviral activity of TNF is mediated via both TNFRs in vivo. Furthermore, these studies establish that TNF is an important component of the host response to a natural virus infection.<\/jats:p>","DOI":"10.1084\/jem.186.9.1591","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:49:30Z","timestamp":1027702170000},"page":"1591-1596","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":102,"title":["Antiviral Activity of Tumor Necrosis Factor (TNF) Is Mediated via p55 and p75 TNF Receptors"],"prefix":"10.1084","volume":"186","author":[{"given":"Janet","family":"Ruby","sequence":"first","affiliation":[{"name":"From the *Viral Engineering and Cytokines Group, Division of Immunology and Cell Biology, John Curtin School of Medical Research, Canberra 2601 Australia; \u2021Department of Microbiology and Immunology, University of Melbourne, Parkville 3052, Victoria Australia; \u00a7Department of Biology, Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, CH-4002, Basel, Switzerland; and \u2016Immunex Research and Development Corporation, Seattle, Washington 98101"},{"name":"From the *Viral Engineering and Cytokines Group, Division of Immunology and Cell Biology, John Curtin School of Medical Research, Canberra 2601 Australia; \u2021Department of Microbiology and Immunology, University of Melbourne, Parkville 3052, Victoria Australia; \u00a7Department of Biology, Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, CH-4002, Basel, Switzerland; and \u2016Immunex Research and Development Corporation, Seattle, Washington 98101"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Bluethmann","sequence":"additional","affiliation":[{"name":"From the *Viral Engineering and Cytokines Group, Division of Immunology and Cell Biology, John Curtin School of Medical Research, Canberra 2601 Australia; \u2021Department of Microbiology and Immunology, University of Melbourne, Parkville 3052, Victoria Australia; \u00a7Department of Biology, Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, CH-4002, Basel, Switzerland; and \u2016Immunex Research and Development Corporation, Seattle, Washington 98101"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J.","family":"Peschon","sequence":"additional","affiliation":[{"name":"From the *Viral Engineering and Cytokines Group, Division of Immunology and Cell Biology, John Curtin School of Medical Research, Canberra 2601 Australia; \u2021Department of Microbiology and Immunology, University of Melbourne, Parkville 3052, Victoria Australia; \u00a7Department of Biology, Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, CH-4002, Basel, Switzerland; and \u2016Immunex Research and Development Corporation, Seattle, Washington 98101"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","reference":[{"key":"2023072507394123200_B1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/323819a0","article-title":"Tumour necrosis factors \u03b1 and \u03b2 inhibit virus replication and synergise with interferons","volume":"323","author":"Wong","year":"1986","journal-title":"Nature (Lond)"},{"key":"2023072507394123200_B2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4049\/jimmunol.140.1.120","article-title":"In vitro anti\u2013human immunodeficiency virus activities of tumor necrosis factor-\u03b1 and interferon-\u03b3","volume":"140","author":"Wong","year":"1988","journal-title":"J Immunol"},{"key":"2023072507394123200_B3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/323816a0","article-title":"Antiviral effects of recombinant tumour necrosis factor in vitro","volume":"323","author":"Mestan","year":"1986","journal-title":"Nature (Lond)"},{"key":"2023072507394123200_B4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1099\/0022-1317-75-1-101","article-title":"Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor","volume":"75","author":"Lucin","year":"1994","journal-title":"J Gen Virol"},{"key":"2023072507394123200_B5","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1073\/pnas.88.9.4025","article-title":"Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo","volume":"88","author":"Sambhi","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072507394123200_B6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0166-3542(93)90012-8","article-title":"Effects of tumor necrosis factor\u2013alpha treatment on mortality in murine cytomegalovirus\u2013infected mice","volume":"21","author":"Anderson","year":"1993","journal-title":"Antivir Res"},{"key":"2023072507394123200_B7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/jvi.69.2.904-909.1995","article-title":"The T-cell\u2013independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections","volume":"69","author":"Heise","year":"1995","journal-title":"J Virol"},{"key":"2023072507394123200_B8","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1099\/0022-1317-74-10-2215","article-title":"Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection","volume":"74","author":"Pavic","year":"1993","journal-title":"J Gen Virol"},{"key":"2023072507394123200_B9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/mpat.1995.0056","article-title":"Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia","volume":"19","author":"Peper","year":"1995","journal-title":"Microb Pathog"},{"key":"2023072507394123200_B10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/1043-4666(90)90040-Z","article-title":"Treatment with anti\u2013tumor necrosis factor alpha does not influence the immune pathological response against lymphocytic choriomeningitis virus","volume":"2","author":"Leist","year":"1990","journal-title":"Cytokine"},{"key":"2023072507394123200_B11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.89.2.846","article-title":"Therapeutic effect of anti\u2013tumor necrosis factor\u2013alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus","volume":"89","author":"Yamada","year":"1994","journal-title":"Circulation"},{"key":"2023072507394123200_B12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0006-291X(91)90929-2","article-title":"T2 open reading frame from the Shope Fibroma Virus encodes a soluble form of the TNF receptor","volume":"176","author":"Smith","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"2023072507394123200_B13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0042-6822(91)90853-4","article-title":"Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to virus virulence","volume":"184","author":"Upton","year":"1991","journal-title":"Virology"},{"key":"2023072507394123200_B14"},{"key":"2023072507394123200_B15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jcb.240530410","article-title":"Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF","volume":"53","author":"Wold","year":"1993","journal-title":"J Cell Biochem"},{"key":"2023072507394123200_B16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1073\/pnas.94.4.1172","article-title":"Death effector domain\u2013containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis","volume":"94","author":"Bertin","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072507394123200_B17","first-page":"93","article-title":"Tumor necrosis factors: developments during the last decade","volume":"7","author":"Aggarwal","year":"1996","journal-title":"Eur Cytokine Netw"},{"key":"2023072507394123200_B18","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.4049\/jimmunol.149.10.3350","article-title":"Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor","volume":"149","author":"Wong","year":"1992","journal-title":"J Immunol"},{"key":"2023072507394123200_B19","first-page":"51","article-title":"Phenotypic analysis of TNFR1-deficient mice and characterization of TNFR1-deficient fibroblasts in vitro","volume":"44","author":"Rothe","year":"1994","journal-title":"Circ Shock"},{"key":"2023072507394123200_B20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/364798a0","article-title":"Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated cytotoxicity but highly susceptible to infection by Listeria monocytogenes.","volume":"364","author":"Rothe","year":"1993","journal-title":"Nature (Lond)"},{"key":"2023072507394123200_B21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/377348a0","article-title":"Induction of apoptosis in mature T cells by tumour necrosis factor","volume":"377","author":"Zheng","year":"1995","journal-title":"Nature (Lond)"},{"key":"2023072507394123200_B22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm0796-788","article-title":"Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors","volume":"2","author":"Bruce","year":"1996","journal-title":"Nat Med"},{"key":"2023072507394123200_B23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.271.5253.1289","article-title":"Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers","volume":"271","author":"Matsumoto","year":"1996","journal-title":"Science (Wash DC)"},{"key":"2023072507394123200_B24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/329545a0","article-title":"Recovery of immunodeficient mice from a vaccinia virus\/IL-2 recombinant infection","volume":"329","author":"Ramshaw","year":"1987","journal-title":"Nature (Lond)"},{"key":"2023072507394123200_B25","first-page":"353","article-title":"The antiviral activity of CD8+T cells is dependent on interferon-\u03b3","volume":"10","author":"Ruby","year":"1991","journal-title":"Lymphokine Cytokine Res"},{"key":"2023072507394123200_B26","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists","volume":"151","author":"Mohler","year":"1993","journal-title":"J Immunol"},{"key":"2023072507394123200_B27","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1128\/jvi.67.7.4214-4226.1993","article-title":"Importance of interferons in recovery from mousepox","volume":"67","author":"Karupiah","year":"1993","journal-title":"J Virol"},{"key":"2023072507394123200_B28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4049\/jimmunol.63.4.341","article-title":"Mousepox (infectious ectromelia of mice): a review","volume":"63","author":"Fenner","year":"1949","journal-title":"J Immunol"},{"key":"2023072507394123200_B29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01487685","article-title":"Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. IV. Studies with the Moscow strain","volume":"100","author":"Bhatt","year":"1988","journal-title":"Arch Virol"},{"key":"2023072507394123200_B30","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1128\/jvi.70.12.8301-8309.1996","article-title":"Different roles for CD4+ and CD8+T lymphocytes and macrophage subsets in the control of a generalized virus infection","volume":"70","author":"Karupiah","year":"1996","journal-title":"J Virol"},{"key":"2023072507394123200_B31","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/jvi.69.8.4792-4796.1995","article-title":"Antiviral defense in mice lacking both alpha\/beta and gamma interferon receptors","volume":"69","author":"van den Broek","year":"1995","journal-title":"J Virol"},{"key":"2023072507394123200_B32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0042-6822(91)90077-O","article-title":"Vaccinia virus homologues of the Shope Fibroma Virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family","volume":"180","author":"Howard","year":"1991","journal-title":"Virology"},{"key":"2023072507394123200_B33","doi-asserted-by":"crossref","first-page":"18542","DOI":"10.1016\/S0021-9258(17)46661-0","article-title":"Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor","volume":"268","author":"Tartaglia","year":"1994","journal-title":"J Biol Chem"},{"key":"2023072507394123200_B34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.180.2.445","article-title":"Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity","volume":"180","author":"Bigda","year":"1994","journal-title":"J Exp Med"},{"key":"2023072507394123200_B35","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4049\/jimmunol.158.2.598","article-title":"TNF receptor-2\u2013triggered apoptosis is associated with the down-regulation of Bcl-xLon activated T cells and can be prevented by CD28 costimulation","volume":"158","author":"Lin","year":"1997","journal-title":"J Immunol"},{"key":"2023072507394123200_B36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.181.2.607","article-title":"Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75","volume":"181","author":"Sheehan","year":"1995","journal-title":"J Exp Med"},{"key":"2023072507394123200_B37","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.4049\/jimmunol.158.5.2398","article-title":"Enhancement of TNF receptor p60\u2013mediated cytotoxicity by TNF receptor p80. Requirement of the TNF receptor\u2013associated factor-2 binding site","volume":"158","author":"Weiss","year":"1997","journal-title":"J Immunol"},{"key":"2023072507394123200_B38","doi-asserted-by":"crossref","first-page":"10784","DOI":"10.1074\/jbc.272.16.10784","article-title":"Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells","volume":"272","author":"Pinckard","year":"1997","journal-title":"J Biol Chem"},{"key":"2023072507394123200_B39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"}],"container-title":["The Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/186\/9\/1591\/1685997\/97-0912.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/186\/9\/1591\/1685997\/97-0912.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T08:23:47Z","timestamp":1690273427000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/186\/9\/1591\/51198\/Antiviral-Activity-of-Tumor-Necrosis-Factor-TNF-Is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11,3]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1997,11,3]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.186.9.1591","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11,3]]}}}